N,N,4-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 250mg

[(3,4-dichlorophenyl)methyl](propyl)amine, 95.0%, 10g

(2-Bromo-4-chloro-3-fluorophenyl)methanol, 98%, 100mg

3-Methylcyclohexanol (cis- and trans- mixture)>98.0%(GC)500mL

Fmoc-N-(propargyl)-glycine, 99.0%, 500mg

(R)-3,3'-Bis[[[(1R,2R)-2-(isoindolin-2-yl)-1,2-diphenylethyl]imino]methyl]-1,1'-bi-2-naphthol>92.0%(HPLC)50mg

(S)-4-(3-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 98%, 250mg

(2R,4R)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 100mg

Naphtho[2,1-b]benzofuran, 97%, 100mg

METHYL 4-AMINO-3-TRIFLUOROMETHOXYBENZOATE, 95.0%, 5g

Provette per centrifuga da 15 ml in PS visivamente trasparente, 1000 Pezzo(i)

Puntali per pipette epT.IPS® 0,1-20 μl, ricarica, PCR clean, 960 pezzi

(5-Bromo-3-methylpyridin-2-yl)methanol, 97%, 1g